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Abstract Although IVF has been performed routinely for many years to help couples with fertility problems and in relation to modern
breeding of farm animals, pregnancy rates after transfer to a recipient have not improved during the last decade. Early prediction
of the viability of in-vitro developed embryos before the transfer to a recipient still remains challenging. Presently, the predomi-
nant non-invasive technique for selecting viable embryos is based on morphology, where parameters such as rates of cleavage and
blastocyst formation as well as developmental kinetics are evaluated mostly subjectively. The simple morphological approach is,
however, inadequate for the prediction of embryo quality, and several studies have focused on developing new non-invasive methods
using molecular approaches based particularly on proteomics, metabolomics andmost recently small non-coding RNA, including microRNA.
This review outlines the potential of several non-invasive in-vitro methods based on analysis of spent embryo culture medium.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction
For decades, in-vitro development of mammalian embryos has
been performed extensively under laboratory conditions, and
the method of choice to assess embryo quality has been based
onmicroscopic observations of morphology. Using this method,
numerous morphological features related to embryo quality
have been described, such as cell cycle timing, compaction
times and cell shape (Holm et al., 1998 [bovine embryos];
Ziebe et al., 1997). Traditionally, morphological evaluation
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of embryo quality has been based on single-time observa-
tions; however, since the early 1980s time-lapse systems have
become available (Massip and Mulnard, 1980). This allowed
for very frequent morphological monitoring, which then has
become a new addition to the range of methods for direct mor-
phological assessment of embryo quality. During the last
10 years further reﬁnements of morphological features moni-
toring have been introduced and semi-automated in a number
of different set-ups (Holm et al., 2002 [bovine embryos];
Pribenszky et al., 2010; Rubio et al., 2014). Still, live birth
rates using assisted reproductive technologies (ART) have not
increased much over recent years (Kupka et al., 2014).
The challenge is to develop predictive methods that balance
the wish to keep the embryo’s viability unaffected by the ob-
servation with the need to obtain very detailed information
to evaluate embryo quality with selection for transfer as the
purpose.
There is a need to ﬁnd other ways of additional or comple-
mentary evaluations, and different approaches have been sug-
gested, mostly reﬂecting the embryo’s function or physiological
state. Studies have also been made to analyse the oocyte’s
surroundings, i.e. its cumulus cells or culture medium, but
these methods have shortcomings and it has not yet been pos-
sible to apply any one of those to routine clinical settings.
This review will therefore focus on outlining the potential for
implementation into a clinical setting of various indirect and
non-invasive in-vitro methods based on analysis of the spent
culture medium of the embryo, within the areas of proteomics,
metabolomics and small non-coding RNAs. One important con-
sideration for the practical applicability of any method is its
speed, in order to provide results within the time frame of
the embryo culture.
Indirect methods based on spent embryo
culture medium
In spent embryo culture medium, the substances of interest
can be divided into three main groups representing three dif-
ferent steps of cellular function: (i) the proteins translated
from the speciﬁc gene expression products of the cells
(proteomics); (ii) the end-products of the biological pro-
cesses of the cells (metabolomics); and (iii) RNA-based nega-
tive regulators of gene expression (small non-coding RNA),
which have been shown to be stable extracellularly (Jung
et al., 2010). The analysis of these molecules is challenging
as they are only present in limited amounts in the culture
medium available for analysis, and thus methods need to be
highly sensitive. The volume of the droplet of culture medium
surrounding the embryo ranges from 15–40 μl in single embryo
cultures to 400–500 μl in group cultures. However, although
group culture results in higher amounts of analytes in the spent
medium, this method does not give the ability to distinguish
between individual embryos. Thus, sensitivity is imperative
for any method to be considered relevant for spent embryo
medium analysis.
Proteomics
The proteome represents all proteins translated from the spe-
ciﬁc gene expression products of a cell at a speciﬁc time and
condition, whereas the embryonic secretome refers to the
proteins produced and secreted by the developing embryo.
The secretome proﬁle of embryos is expected to change ac-
cording to the viability of the embryo (Katz-Jaffe and Gardner,
2008), but unfortunately knowledge of the embryonic
proteome and secretome is very limited. This, combined with
constraints of proteomic technology, has been highly limit-
ing for the development and application of proteomics for
characterization of embryos. However, new technological ad-
vances, including increased platform sensitivity, have allowed
discovery of potential biomarkers (Katz-Jaffe and McReynolds,
2013). These advances are still impeded by technical prob-
lems associated with the reagents used for embryo cul-
tures, in particular because many laboratories use serum
containing albumin as a protein source in the culture medium.
It has not yet been possible to ﬁnd a replacement for albumin,
as the growth of the embryos has been shown to be affected
by alternatives to albumin (Mains et al., 2011). The pres-
ence of albumin in the serum makes it very difﬁcult to detect
proteins with a molecular weight corresponding to that of
serum albumin (60–70 kDa) using methods that are cost-
efﬁcient and applicable to IVF laboratories (Mains et al., 2011).
Several attempts have been made to establish consistent
protein biomarkers in embryonic medium. In 2009 Katz-
Jaffe et al. reviewed ﬁndings on potential protein biomarkers
in the embryo secretome (Katz-Jaffe et al., 2009), includ-
ing platelet-activating factor, leptin, agrocranin, human leu-
kocyte antigen G (HLA-G) and ubiquitin. Although these all
appear to be promising biomarkers for prediction of trans-
fer success, only HLA-G has been investigated in a clinical
setting for its ability to predict pregnancy outcome. HLA-G
has strong immunosuppressive functions and is thought to be
one of the most important factors in reshaping the mater-
nal immune response into tolerating the fetus (Jurisicova et al.,
1996). However, in spite of several promising proof-of-
concept studies (Desai et al., 2006; Fisch et al., 2007; Fuzzi
et al., 2002; Noci et al., 2005; Rebmann et al., 2007; Shaikly
et al., 2008; Sher et al., 2004, 2005a, 2005b; Yie et al., 2005),
multi-centre trials have found that HLA-G does not offer any
clinical advantages compared with morphological scoring,
which seems to be due to variation in HLA-G contents in em-
bryonic media between different ART centres (Rebmann et al.,
2010; Tabiasco et al., 2009).
More recently, the focus has been on highly multiplexed
proteomic methods, such as mass spectrometry (MS). Using
such methods Cortezzi et al. (2011) identiﬁed 25 proteins in
the secretome, of which 15 predicted positive pregnancy
outcome and 10 were associated with negative pregnancy
outcome. The Jumonji protein (JARID2) was the most repre-
sented of the proteins that predicted positive pregnancy
outcome. JARID2 is part of a histone methyltransferase
complex that is involved in the regulation of embryonic pat-
terning genes (Pasini et al., 2010). However, none of these
proteins were investigated as clinical biomarker in random-
ized controlled trials. MS was also used to establish that the
concentration of apolipoprotein A1 (ApoA1) in spent embryo
medium was higher at culture day 4–5 of embryos of higher
morphological grade compared with abnormal embryos (Mains
et al., 2011); however, the concentration of ApoA1 in the
spent medium was not correlated with pregnancy outcomes.
ApoA1 is associated with high-density lipoprotein (HDL)
(Santos-Gallego et al., 2008) and plays a key role in
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cholesterol transport (Brunham et al., 2006). This study was
elaborated in Nyalwidhe et al. (2013) focusing on the
secretome of day 2–3 embryos using MS, in which ApoA1 was
also found to be highly represented; however, in this study
ApoA1 was less abundant in the samples associated with suc-
cessful pregnancy compared with those that were not. The
authors conﬁrmed this using enzyme-linked immunosorbent
assay (ELISA) and western blotting on pooled media samples.
Based on these results and earlier data the authors sug-
gested that ApoA1 internalization could be characteristic of
viable embryos leading to a correlation between successful
transfer and low concentrations of ApoA1 in the secretome
early in development. This was further substantiated by the
ﬁnding of ApoA1 mRNA transcripts in day 5 blastocysts but not
in day 3 embryos (Mains et al., 2011), indicating a higher in-
tracellular concentration of ApoA1 in the blastocyst com-
pared with the embryos. In a recent study of the proteome
of bovine embryos (Deutsch et al., 2014), proteins involved
in lipid metabolism decreased during embryo development,
and in particular ApoA1 abundance decreased by 1.6-fold from
the oocyte stage to the 4-cell stage. The authors speculated
that this decrease might be caused by an increased secre-
tion by the embryo into the culture medium during embryo-
genesis. Unfortunately, in this study there was no
discrimination between viable and non-viable embryos, nor
an investigation into the secretomic proﬁle of ApoA1 to support
the human data of differences in the ApoA1 abundance in the
spent embryo medium.
In another approach, Butler et al. (2013) used MS to in-
vestigate the hormone human chorionic gonadotrophin (HCG)
in the secretome. As a signal for maternal recognition of preg-
nancy, HCG has long been used as an obstetric marker for em-
bryonic development (Cole, 2009). The authors speculated that
different isoforms of HCG could predict the transfer success
of the embryo. Out of four isoforms, HCGβ appeared to have
potential as a biomarker as it was detectable in the spent
medium as early as at the 2-cell stage in some samples using
both MS and immunoassays, along with concurrent gene ex-
pression. It was not possible to detect HCG in the spent
medium prior to embryo hatching (on day 6 for the human
embryo). Furthermore, it seemed that the presence of the
HCGh isoform early in development might be an indicator of
pathology, as it was detected in the culture medium of ab-
normal (3-pronuclei) embryos. However, this study did not
correlate the data to pregnancy outcomes, only to embryo
morphology.
Although there is a lot of activity in the area of discover-
ing secretome biomarkers, a number of huge obstacles must
be overcome before early, sensitive and consistent protein
biomarkers of embryo quality can be found. Apart from the
restrictions already mentioned (small sample volumes, low
analyte concentrations), other practical and ethical con-
cerns make it difﬁcult to perform detailed assessments of po-
tential biomarkers in humans; for example, single embryo
transfers are not a realistic approach in most fertility labo-
ratories, which makes the determination of the accurate preg-
nancy rates a problem. Furthermore, the data are confounded
by the fact that most proteome studies are performed on
pooled samples, making it difﬁcult to distinguish between dif-
ferent embryos outcomes. In order to increase the utility of
proteomics for prediction of success of embryo transfer,
further development of proteomic technologies is therefore
needed so that single samples and even lower protein con-
centrations can be measured. Furthermore, the increased pos-
sibility to design proper experiments in model animal embryo
cultures could be pursued even more and more basic inves-
tigations in appropriate animal models will be needed.
Mass spectrometry-based proteomics methods have the ad-
vantage of speed compared with traditional immunochemi-
cal methods such as ELISA and therefore possess a greater
potential for application to ART.
Metabolomics
Metabolomics provides a snapshot of the concentrations of
all metabolites in the culture medium as detected by the
applied method. Metabolites can change according to the
metabolic or environmental state of a cell. The metabolome
(small molecule metabolites found within a biological sample)
therefore is a good indicator of cellular activity, and may
present good biomarkers for viable embryos having a high prob-
ability of success after transfer. In contrast to genomics and
proteomics, metabolomics deals with diverse classes of mol-
ecules, such as amino acids, oxidation products, carbohy-
drates and carboxylic acids (Nagy et al., 2008).
The most intensively studied class of non-invasive
biomarkers is the secreted metabolome, and several prom-
ising metabolite biomarkers have been discovered (the most
recent are shown in Table 1 and further are reviewed in Botros
et al., 2008 and Nel-Themaat and Nagy, 2011). Until re-
cently, most efforts have used spectroscopy, especially near
infrared (NIR) spectroscopy, for investigating possible links
between the metabolome and embryo viability. This tech-
nology measures vibrations of functional groups in a sample
without identifying speciﬁc metabolites, leading to the gen-
eration of a viability score by comparing regions within the
NIR spectral proﬁles (Botros et al., 2008). The purpose is to
derive a uniﬁed measure discriminating between viable and
non-viable embryos (Ahlström et al., 2011). The advantages
of NIR include that measurements can be made directly on
even small sample volumes (<15 μl), with no requirements for
sample preparation and with results being available within
1 minute per sample (Seli et al., 2007). This is in contrast to
other spectroscopic platforms, such as Raman and nuclear
magnetic resonance (NMR) spectroscopy, characterized by ex-
pensive and complicated equipment, low sensitivity, lengthy
and extensive sample processing, or the need for complex sta-
tistical analysis for interpretation of results making them im-
practical in clinical settings (Rinaudo et al., 2012; Seli et al.,
2010).
Several studies have focused on NIR as a potential way to
assess embryo viability, whether used alone or in conjunc-
tion with morphology assessments, and results have been
promising (Ahlström et al., 2011; Fu et al., 2013; Nagy et al.,
2008, 2009; Seli et al., 2010, 2011; Vergouw et al., 2008,
2011). However, randomized controlled clinical trials have gen-
erally shown that NIR-based metabolomics proﬁling did not
offer any advantage over morphologic assessment of embryos.
In a meta-analysis of four such studies, the live birth rates
were 34.7% in the control group and 33.2% in the NIR group,
which was not a signiﬁcant difference (Vergouw et al., 2014).
A problem in most NIR studies is a large intra-group varia-
tion, which can lead to both false positive and false negative
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predictions. In 2013 an NIR instrument prototype speciﬁ-
cally developed for clinical practice in ART centres was with-
drawn from the market (Molecular Biometrics, Norwood, MA,
USA) (Uyar and Seli, 2014), and the present status is that the
NIR technology needs to be improved and retested before new
attempts to use it for assessment of embryo viability can be
made, which will happen as we get more knowledge about
the embryonic metabolomic proﬁle.
Recent efforts have utilized other spectroscopy methods.
One is a variant of NIR, namely Fourier transform infrared
(FTIR) spectroscopy, which has been used to predict preg-
nancy viability of bovine embryos. The studies were per-
formed with spent medium collected at day 7 from in-vivo
(embryos recovered at day 6) and in-vitro produced embryos
(Muñoz et al., 2014a, 2014b). Although the authors found that
the metabolome of the spent culture medium was different
between embryos that were successfully transferred (end-
points were day 60 pregnancy and live birth) compared with
those that were not, FTIR-based metabolomic proﬁling did not
lead to higher speciﬁcity of prediction of transfer success com-
pared with conventional embryo selection methods. However,
when applied to a subgroup of in-vitro expanded blasto-
cysts, which accounted for 66% of the embryos transferred
in this study, the FTIR-based metabolomic proﬁle of spent
culture mediumwas correlated with a substantially higher birth
rate than when the method was applied to embryos of all
stages (82.8% versus 72.2%, respectively) (Muñoz et al., 2014a).
Furthermore, the authors found that differences in the treat-
ment of embryos (fresh or vitriﬁed) and between the labo-
ratories that handled the embryos introduced differences in
the FTIR proﬁle of spent culture media (Muñoz et al., 2014a,
2014b). Although there is potential in using FTIR to predict
transfer success, as the method is fast, easy to handle and
inexpensive, it is limited by the relatively small amount of
validated data in presently available databases (Muñoz et al.,
2014a). Furthermore, the studies done so far using FTIR have
not been blinded, which is a reason for caution.
Finally, a number of recent studies on metabolic proﬁl-
ing have used NMR spectroscopy, which is able to identify spe-
ciﬁc metabolites, unlike NIR (Rinaudo et al., 2012). Results,
however, are ambiguous. Pudakalakatti et al., 2013 found that
a low pyruvate/alanine ratio in embryo culture medium on
day 3 (but not on day 2) was correlated with successful trans-
fer, and Wallace et al. (2014) identiﬁed and quantiﬁed 12 me-
tabolites in spent embryo medium, of which seven had not
been investigated before in relation to prediction of pregnancy
success. They found that the ratios between these
metabolites on day 2 differed between embryos that were suc-
cessfully transferred and those that were not, and there-
fore suggested the use of such ratios for predicting transfer
success. However, other studies have found that NMR cannot
be used to predict transfer success using multivariate analy-
sis. For example, Rinaudo et al. (2012) investigated the NMR
proﬁle of day 3 spent embryo medium and found that
Table 1 Overview of recent metabolomic ﬁndings.
Study
Method Species Day Sample size Findings
Wiener-Megnazi et al.,
2011
TLC Human 2 and 3 133 patients–284
embryos
Oxidative status can be used as a transfer
marker at day 3
Vergouw et al., 2011 NIR Human 5 115 patients–127
embryos
Correlation between increased viability
score and live-birth outcome
Seli et al., 2011 NIR Human 5 198 embryos Viability score better indicator for transfer
outcome than morphologic grading
Gardner et al., 2011 Micro-
ﬂuorimetry
Human 4 and 5 50 patients–50
embryos
Increased glucose uptake indicates higher
pregnancy rate and female embryos have
higher uptake than male
Combelles et al., 2012 ELISA Human 3 91 patients–122
embryos
SOD1 (superoxide dismutase-1) cannot be
used as a biomarker for transfer potential
Pudakalakatti et al.,
2013
1H NMR Human 2 and 3 48 patients–127
embryos
Pyruvate/alanine ratio can predict transfer
outcome at day 3
Fu et al., 2013 NIR Human 3 172 patients–239
embryos
Viability index predicts transfer outcomes
Wallace et al., 2014 1H NMR Human 2 37 patients–58
embryos
The ratios between different metabolites
are correlated with transfer potential
Kirkegaard et al., 2014 1H NMR Human 3 and 5 161 patients–148
embryos
No correlation between NMR variations and
pregnancy outcome
Vergouw et al., 2014 NIR Human 924 patients Meta-analysis of four studies: NIR proﬁling
does not improve birth rates
Muñoz et al., 2014a FTIR Bovine 6 and 7 69 embryos In a subgroup of blastocysts, using FTIR is
correlated with higher birth rates
Muñoz et al., 2014b FTIR Bovine 7 49 embryos FTIR proﬁling correlates with viability of in
vivo embryos however is affected by embryo
management procedures
ELISA = enzyme-linked immunosorbent assay; FTIR = Fourier transform infrared spectroscopy; 1H NMR = proton nuclear magnetic resonance
spectroscopy; NIR = near infrared spectroscopy; TLC = thermochemiluminescence.
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implanted and non-implanted embryos did not show consis-
tently different NMR proﬁles. Interestingly, these authors com-
pared the proﬁles of three different types of spent embryo
media, and found that the medium composition profoundly
affected the NMR proﬁle. As different IVF laboratories use dif-
ferent types of culture media and as manufacturers continu-
ously change and improve culture media, this presents a major
problem with this method. So far, Kirkegaard et al. (2014) is
the only study using NMR to only include spent embryo medium
from single transferred embryos, making it possible to assess
the transfer success of each embryo. They investigated spent
embryo medium from day 3 and 5 embryos and found that in
spite of a high degree of individual metabolomic variation,
it could not be associated with pregnancy outcome. It is not
clear why conclusions of these four studies are this differ-
ent; however, one reason could be differences in the sample
sizes. Both of the studies that did not ﬁnd any correlation
between NMR proﬁles and transfer success used larger sample
sizes (n = 108 and 161, respectively) compared with the studies
that did ﬁnd a correlation (n = 48 and 37, respectively). These
ﬁndings, coupled with the fact that NMR as a method is not
readily applicable in a clinical setting, due to the cost and
size of the equipment as well as the special expertise re-
quired (Rinaudo et al., 2012), the potential for using NMR as
a practical clinical tool for predicting embryo transfer success
remains low at present.
In conclusion, although the area of metabolomics has been
heavily investigated as a way to predict embryo viability, and
several possible biomarkers have been identiﬁed (summa-
rized in Table 1), no single or composite early, consistent and
sensitive biomarker for clinical use has been established.
However, advances in the technology and the databases may
change this in the future, and spectroscopic methods such as
IR and NMR are fast and potentially readily applicable to
embryo quality prediction in an ART setting.
Small non-coding RNA
Recently, a new approach to non-invasive screening of spent
embryo mediumwas suggested. It involves detecting microRNA
(miRNA) directly in the spent embryo medium. The impor-
tance of small non-coding RNA, such as miRNA, for
embryogenesis and development is clearly established (re-
viewed in Galliano and Pellicer, 2014) both in humans and
in other species of interest, including pigs (Prather et al.,
2009), cattle (Goossens et al., 2013) and chickens (Darnell
et al., 2006). miRNA are small (18–22 nucleotides), non-
coding RNA molecules that are mostly considered to be
negative regulators of gene expression as they can destabi-
lize or repress translation of messenger RNA (mRNA) (Bagga
et al., 2005; Wu et al., 2006). One type of miRNA can poten-
tially regulate more than a hundred different target genes
(Lim et al., 2005). Interestingly, the presence of miRNA has
been detected in almost all bioﬂuids including tears, blood,
urine, breast milk and semen (Weber et al., 2010), and in
cell culture medium (for example Valadi et al., 2007). Fur-
thermore, extracellular miRNA is very stable and resistant
to degradation (Jung et al., 2010). This might be due to the
encapsulation of at least some extracellular miRNA in small
membrane-derived vesicles called exosomes, which can be
delivered to other cells and thereby impact the gene expres-
sion in those cells (Valadi et al., 2007).
In humans, the miRNA proﬁle of blastocysts was found to
be aberrant in blastocysts from groups of patients with either
male factor infertility or polycystic ovaries compared with blas-
tocysts from patients with normal fertility, even though the
blastocysts had the same overall morphological quality
(McCallie et al., 2010). In this study, the expression of 12
miRNAs was investigated in three blastocyst types, and clear
differences in the miRNA proﬁles of the blastocysts from the
infertile patients compared with blastocysts from patients with
normal fertility were found.
In 2013, the group of Katz-Jaffe and McReynolds analysed
spent blastocyst culture medium and failed to detect any of
the 377 miRNAs in their analysis panel (Katz-Jaffe and
McReynolds, 2013). Since then the sensitivity of methods
for identifying miRNAs has greatly increased, leading to two
studies published in 2014 claiming that embryos do indeed
secrete miRNA into the culture medium, and that the miRNA
proﬁle could possibly be used as a biomarker to predict
transfer success (Kropp et al., 2014 [bovine and human
embryos]; Rosenbluth et al., 2014). Rosenbluth et al. (2014)
studied 754 human miRNA and found that three (miR-372,
miR-191 and miR-645) were differentially expressed on day
5 between the spent culture medium of embryos that had
successful pregnancy outcomes and spent culture medium
from embryos that did not lead to pregnancy. No correla-
tion was found between the miRNA proﬁle and pregnancy
outcome in the spent culture medium of embryos produced
by intracytoplasmic sperm injection (ICSI), or when the spent
culture medium of IVF embryos and ICSI embryos were pooled.
The miRNA concentrations were too low to be detectable at
earlier time points. Interestingly, it was also discovered
that miR-191 was found in higher concentrations in the spent
culture medium of aneuploid embryos compared with euploid
embryos. Kropp et al. (2014) studied ﬁve miRNAs in bovine
and human embryos and in spent embryo medium of either
embryos that developed into blastocysts or degenerate
embryos (day 8 in cattle and day 6 in humans). They found
three of the ﬁve miRNA in the medium (miR-25, miR-181a
and miR-370), but with no difference in amounts or miRNA
ratios between the two embryo types. However, miR-196a2
was only found in the medium of abnormal blastocysts and
blank medium, leading to the authors suggesting that it was
taken up by viable blastocysts. Interestingly, these authors
found a difference in the miRNA gene expression of the
blastocyst compared with the miRNA found in the medium,
suggesting that embryos selectively secrete or take up certain
miRNAs. Unfortunately, this investigation was hampered by
the fact that the spent culture medium was pooled and that
only ﬁve miRNAs were investigated. Furthermore, the authors
did not investigate whether there was any correlation between
pregnancy rates and miRNA proﬁle.
The miRNA results are promising and indicate that the
types and amounts of miRNA secreted into the culture
medium might differ between viable and non-viable embryos.
The general interest in using miRNA as disease biomarkers is
growing rapidly, also speeding up the development of new
and more sensitive methods for detection of miRNA in
bioﬂuids, leading to more generally applicable and easier to
use methods. The quantitative real-time polymerase chain
reaction (qPCR) method is fast, relatively cheap and can be
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used with very small sample sizes. Although some sample
pre-treatment is needed, this makes it a candidate as a tool
to detect miRNA biomarkers in embryo culture medium as
the test can be performed in-house on the spent embryo
medium before transfer. However, it is clear that more
investigations are needed into more types of miRNA, in
larger experimental settings with more samples, and in
different laboratories using different types of culture media,
so hopefully it will be possible to identify an early, sensi-
tive, distinctive miRNA proﬁle to select the embryos having
the best chance of pregnancy and birth.
Conclusion
The area of non-invasive screening of embryo quality is a very
active one and the focus remains on identifying non-invasive
biomarker-based methods to supplement the traditional mor-
phological assessment. In the ﬁeld of metabolomics espe-
cially the methods using infrared spectroscopy (NIR and FTIR)
might be candidates for clinical applications, as they are rapid
and easy to handle, and the miRNA proﬁling of embryo medium
using qPCR certainly has potential as well. Both qPCR and MS-
based proteomics require some level of sample pre-treatment
before analysis and also do demand some time for the analy-
sis itself; however, this can still be ﬁtted within the ART
scheme. The main challenges with the use of these methods
in a clinical setting remain low platform sensitivity, issues with
the practical management of cultures and samples (for
example, different types of embryo culture media used in dif-
ferent IVF laboratories or the use of double embryo trans-
fer) and lack of knowledge of the biological processes in the
developing embryos such as the limitations of the metabolomic
databases and of regulation of miRNA.
Even so, several potential possible biomarkers have been
proposed, especially in the ﬁeld of metabolomics (see
Table 1), although this has not so far resulted in higher preg-
nancy or birth rates, and at present no biomarker clearly stands
out as a potential early, consistent and sensitive means of pre-
dicting transfer success. However, this will hopefully change
within the next few years as technologies keep improving, and
as new biological discoveries are made. Furthermore, more
studies are utilizing animal models to increase the under-
standing of the complex system of embryogenesis in mammals.
Until then, the use of morphological assessment of pre-
transfer embryos continues to be the best tool for assess-
ment of embryo quality.
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